Peter E. Cadman

632 total citations
14 papers, 506 citations indexed

About

Peter E. Cadman is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Peter E. Cadman has authored 14 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cell Biology. Recurrent topics in Peter E. Cadman's work include Receptor Mechanisms and Signaling (5 papers), Cellular transport and secretion (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Peter E. Cadman is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Cellular transport and secretion (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Peter E. Cadman collaborates with scholars based in United States, Sweden and Spain. Peter E. Cadman's co-authors include Daniel T. O’Connor, Fangwen Rao, Sushil K. Mahata, Gen Wen, Nicholas J. Schork, Manjula Mahata, Rany M. Salem, Laurent Taupenot, Bruce A. Hamilton and Mats Stridsberg and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Annals of the New York Academy of Sciences.

In The Last Decade

Peter E. Cadman

14 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter E. Cadman United States 13 236 110 107 85 83 14 506
Gloria Padoani Italy 12 223 0.9× 94 0.9× 78 0.7× 66 0.8× 20 0.2× 22 474
Rachel M. Mayers United Kingdom 10 143 0.6× 209 1.9× 142 1.3× 26 0.3× 37 0.4× 11 572
Jun Namkung South Korea 11 236 1.0× 152 1.4× 76 0.7× 74 0.9× 29 0.3× 21 717
Simon H. Ridley United Kingdom 7 193 0.8× 104 0.9× 62 0.6× 44 0.5× 24 0.3× 10 643
Chunmin C. Lo United States 14 158 0.7× 129 1.2× 66 0.6× 63 0.7× 20 0.2× 27 504
M. Grohmann Germany 14 258 1.1× 64 0.6× 147 1.4× 68 0.8× 34 0.4× 23 549
Samuel Gallant United States 16 274 1.2× 374 3.4× 74 0.7× 74 0.9× 35 0.4× 36 680
C. B. Hensley United States 13 444 1.9× 106 1.0× 44 0.4× 87 1.0× 59 0.7× 15 564
Maggie S. McIntyre United States 9 272 1.2× 66 0.6× 73 0.7× 64 0.8× 42 0.5× 9 464
Bu‐Chin Yu Taiwan 11 210 0.9× 96 0.9× 54 0.5× 23 0.3× 13 0.2× 14 512

Countries citing papers authored by Peter E. Cadman

Since Specialization
Citations

This map shows the geographic impact of Peter E. Cadman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Cadman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Cadman more than expected).

Fields of papers citing papers by Peter E. Cadman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Cadman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Cadman. The network helps show where Peter E. Cadman may publish in the future.

Co-authorship network of co-authors of Peter E. Cadman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Cadman. A scholar is included among the top collaborators of Peter E. Cadman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Cadman. Peter E. Cadman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hulley, Benjamin J., et al.. (2023). Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(12). 1297–1306. 1 indexed citations
2.
Cadman, Peter E.. (2016). Hypophosphatemia in Users of Cannabis. American Journal of Kidney Diseases. 69(1). 152–155. 16 indexed citations
3.
Salem, Rany M., Peter E. Cadman, Yuqing Chen, et al.. (2008). Chromogranin A Polymorphisms Are Associated With Hypertensive Renal Disease. Journal of the American Society of Nephrology. 19(3). 600–614. 48 indexed citations
4.
Rao, Fangwen, Lian Zhang, Jennifer Wessel, et al.. (2008). Adrenergic Polymorphism and the Human Stress Response. Annals of the New York Academy of Sciences. 1148(1). 282–296. 15 indexed citations
5.
Rao, Fangwen, Lian Zhang, Jennifer Wessel, et al.. (2007). Tyrosine Hydroxylase, the Rate-Limiting Enzyme in Catecholamine Biosynthesis. Circulation. 116(9). 993–1006. 73 indexed citations
6.
Zhang, Kuixing, Fangwen Rao, Gen Wen, et al.. (2006). Catecholamine storage vesicles and the metabolic syndrome: the role of the chromogranin A fragment pancreastatin. Diabetes Obesity and Metabolism. 8(6). 621–633. 25 indexed citations
7.
O’Connor, Daniel T., Peter E. Cadman, Rany M. Salem, et al.. (2005). Pancreastatin: Multiple Actions on Human Intermediary Metabolismin Vivo, Variation in Disease, and Naturally Occurring Functional Genetic Polymorphism. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5414–5425. 68 indexed citations
8.
Chopra, Shruti, Janie Smith, Peter E. Cadman, et al.. (2005). Human response to α-adrenergic agonist stimulation studied in an isolated vascular bed in vivo: Biphasic influence of dose, age, gender, and receptor genotype. Clinical Pharmacology & Therapeutics. 77(5). 388–403. 23 indexed citations
9.
Hall, Stephen D., David A. Flockhart, Lang Li, et al.. (2005). Association Between the CYP3A5 Genotype and Blood Pressure. Hypertension. 45(2). 294–298. 71 indexed citations
10.
Wen, Gen, Sushil K. Mahata, Peter E. Cadman, et al.. (2004). Both Rare and Common Polymorphisms Contribute Functional Variation at CHGA, a Regulator of Catecholamine Physiology. The American Journal of Human Genetics. 74(2). 197–207. 90 indexed citations
11.
Greenwood, Tiffany A., Peter E. Cadman, Mats Stridsberg, et al.. (2004). Genome-wide linkage analysis of chromogranin B expression in the CEPH pedigrees: implications for exocytotic sympathochromaffin secretion in humans. Physiological Genomics. 18(1). 119–127. 12 indexed citations
12.
Cadman, Peter E. & Daniel T. O’Connor. (2003). Pharmacogenomics of hypertension. Current Opinion in Nephrology & Hypertension. 12(1). 61–70. 19 indexed citations
13.
Cadman, Peter E. & Daniel T. O’Connor. (2003). Pharmacogenomics of hypertension.. PubMed. 12(1). 61–70. 25 indexed citations
14.
Cadman, Peter E., Fangwen Rao, Sushil K. Mahata, & Daniel T. O’Connor. (2002). Studies of the Dysglycemic Peptide, Pancreastatin, Using a Human Forearm Model. Annals of the New York Academy of Sciences. 971(1). 528–529. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026